Phase 4 Trial Involving Insulin Glargine Comparator Completed

A clinical trial update involving insulin glargine was recorded on September 28, 2026. The trial, registered as NCT06370715 and titled "A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India," has reached COMPLETED status. This was a Phase 4 study conducted in adult participants with Type 2 diabetes mellitus in India. Phase 4 studies are conducted after a drug has received regulatory approval and typically gather additional data in real world or specific populations. The completion status reflects the trial's progression through its planned conduct as of the listed date. No results or outcome data are included in this update. The study registration can be found under the identifier NCT06370715 on ClinicalTrials.gov. Insulin glargine is an approved compound, and this trial update does not alter that regulatory status. Readers should note that completion of a trial refers to the conclusion of the study's conduct, not necessarily the availability or interpretation of results. Further details on the study design, enrollment, and any eventual results would be found through the official trial registration. For more background on insulin glargine, including its approved uses and general information, readers can refer to the compound overview.